HAG
HighPoint Advisor Group’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.47M | Buy |
50,948
+30,394
| +148% | +$3.26M | 0.29% | 60 |
|
2025
Q1 | $2.11M | Buy |
20,554
+125
| +0.6% | +$12.8K | 0.12% | 137 |
|
2024
Q4 | $2.05M | Buy |
20,429
+1,683
| +9% | +$169K | 0.11% | 148 |
|
2024
Q3 | $1.57M | Sell |
18,746
-7,052
| -27% | -$591K | 0.09% | 172 |
|
2024
Q2 | $1.91M | Buy |
25,798
+13,957
| +118% | +$1.03M | 0.11% | 143 |
|
2024
Q1 | $862K | Buy |
11,841
+3,720
| +46% | +$271K | 0.06% | 242 |
|
2023
Q4 | $546K | Buy |
+8,121
| New | +$546K | 0.04% | 336 |
|
2022
Q2 | $207K | Buy |
+5,493
| New | +$207K | 0.02% | 485 |
|
2021
Q3 | $221K | Sell |
5,094
-712
| -12% | -$30.9K | 0.02% | 488 |
|
2021
Q2 | $248K | Buy |
+5,806
| New | +$248K | 0.03% | 443 |
|